OVID
Ovid Therapeutics Inc
2.40$
-2.4%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | – | – | – | – | 91.9% | 407.4% | 106.0% | 4.1% | |
| – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 95.9% | |
| – | – | – | – | – | – | 502.6% | 22.5% | 1,638.2% | 7,292.9% | 6,495.9% | 352.8% | |
| – | – | – | – | – | – | 242.8% | 17.9% | 2,158.2% | 7,547.2% | 4,537.6% | 332.4% | |
| – | – | – | – | – | – | 745.4% | 40.4% | 3,796.4% | 15,222.7% | 11,033.7% | 681.1% | |
| – | – | – | – | – | – | -645.4% | 59.6% | -3,696.4% | -15,122.7% | -10,933.7% | -585.2% | |
| – | – | – | – | – | – | 0.0% | 0.0% | 183.7% | – | – | – | |
| – | – | – | – | – | – | -642.3% | 59.6% | -3,604.7% | -13,351.8% | -4,670.1% | -240.1% | |
| – | – | – | – | – | – | -2.4% | 0.6% | -183.7% | 0.0% | – | – | |
| – | – | – | – | – | – | -639.8% | 58.9% | -3,421.0% | -13,351.8% | -4,670.1% | -240.1% | |
| – | – | – | – | – | – | -643.0% | 59.7% | -3,604.5% | -14,544.1% | -10,207.1% | -236.0% |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.